THE ASSOCIATION BETWEEN OXYGEN EXPOSURE AND NEONATAL MORBIDITY AND THE DEVELOPMENT OF RETINOPATHY OF PREMATURITY IN PRETERM INFANTS

Authors

  • Khashimova Shakhnoza Isroil qizi Tashkent State Medical University image/svg+xml Author

Abstract

Retinopathy of prematurity (ROP) is a potentially sight-threatening disorder affecting the developing retinal vasculature of infants born prematurely. Although advances in neonatal intensive care have improved survival among very preterm infants, these children remain vulnerable to complications associated with incomplete organ development. ROP is particularly important because severe disease may result in permanent visual impairment, while timely detection and appropriate treatment can prevent many adverse outcomes. Gestational age and birth weight are well-established indicators of ROP susceptibility. However, infants with similar birth characteristics may experience different disease outcomes depending on their clinical condition after delivery. Respiratory instability, prolonged oxygen supplementation, bronchopulmonary dysplasia, sepsis, and other neonatal complications may provide additional information about the likelihood of ROP development. Understanding these associations is important for improving clinical risk assessment and identifying infants who require particularly careful ophthalmological surveillance. To examine the relationship between oxygen exposure, major neonatal complications, and the development of ROP in preterm infants, with particular attention to factors associated with severe or treatment-requiring disease.

References

1. Yu CW, Popovic MM, Dhoot AS, et al. Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies. Neonatology. 2022;119(2):151–163. doi:10.1159/000519635.

2. Bahmani T, Karimi A, Rezaei N, Daliri S. Retinopathy of prematurity: a systematic review and meta-analysis study based on neonatal and maternal risk factors. The Journal of Maternal-Fetal & Neonatal Medicine. 2022;35(25):8032–8050. doi:10.1080/14767058.2021.1940938.

3. Estrada MM, Tomlinson LA, Yu Y, Ying GS, Binenbaum G; G-ROP Study Group. Daily oxygen supplementation and risk of retinopathy of prematurity. Ophthalmic Epidemiology. 2023;30(3):317–325. doi:10.1080/09286586.2022.2111687.

4. Shemesh R, Strauss T, Zaslavsky-Paltiel I, et al. Perinatal and neonatal risk factors for retinopathy of prematurity in very low birthweight, very preterm twins: a population-based study. Eye. 2024;38:902–909. doi:10.1038/s41433-023-02801-8.

5. Shen L, Zheng R, Sun X, Chen S. Development and validation of a multivariate nomogram for predicting retinopathy of prematurity in infants with gestational age ≤34 weeks. Frontiers in Pediatrics. 2025;13:1576979. doi:10.3389/fped.2025.1576979.

6. Akkawi MT, Shehadeh MM, Shams ANA, et al. Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine. BMC Ophthalmology. 2019;19:189.

Downloads

Published

2026-10-13